Chronic kidney failure stage 5. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Consumption of VM-protein powder in the amount of 24 grams orally manufactured by Iran Daru Company for 6 months on a daily basis (within 6 months from the start of the study). Interve
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 20-70 years albumin1
Exclusion criteria
Exclusion criteria: lack of informed consent for participating history of chronic diseases such as liver diseases, malignancies, severe cardiopulmonary diseases history of any surgery within past 3 months history of hospitalization due to malignancies within past 3 months history of allergy due to oral nutritional supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bio-impedance device analysis. Timepoint: At the beginning of the study (before the start of the intervention) and 6 months after the start of VM protein. Method of measurement: Bio-impedance device. | — |
Secondary
| Measure | Time frame |
|---|---|
| MUST score. Timepoint: before the start of the intervention and six months after the start of vm protein. Method of measurement: Malnutrition Universal Screening Tool (MUST). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Saberian
Shahid Beheshti University of Medical Sciences
Outcome results
None listed